The field of chemical site-selective modification of proteins has progressed extensively in recent decades to enable protein functionalization for imaging, drug delivery, and functional studies. In this Perspective, we provide detailed insight into an alternative use of site-selective protein chemistry to probe the role(s) of unpaired Cys residues in the structure and function of disease relevant proteins. Phosphatases are important players in the successful infection of pathogenic bacteria, which represent a significant health burden, particularly in multi-drug-resistant strains. Therefore, a strategy for readily probing the key amino acid role(s) in structure and function may facilitate the targeting and inhibition of these virulence factors. With a dehydroalanine-based posttranslational chemical mutagenesis approach, it is possible to reveal hitherto unknown function(s) of noncatalytic Cys residues and confirm their role and interplay in pathogenic bacterial phosphatases. By selectively modifying reactive sulfhydryl side chains in different protein local environments, this posttranslational site-selective chemical mutagenesis approach reveals structural information about binding pockets and regulatory roles of the modified residues, which can be further validated by conventional site-directed mutagenesis. Ultimately, these new binding pockets can serve as templates for enhanced structurebased drug design platforms and aid the development of potent and specific inhibitors.
C ysteine (Cys) plays key roles in protein function and stability even though it is one of the least abundant amino acids. Its appearance on the genetic code is rather late, 1 but its accumulation continues in modern organisms. 2 Cys residues have a unique set of chemical properties, such as the ability to form disulfide bridges and to operate as redox switches 3 because of the high nucleophilicity of the sulfhydryl side chain (R-SH). 4 The thiol can be alkylated by electrophiles and oxidized by reactive oxygen (ROS) and nitrogen species (RNS), 5 which presents a challenge to proteins that contain highly reactive Cys, hence their tightly regulated expression under oxidative stress. 6 As a safety mechanism, many of these proteins express key Cys residues in buried motifs 7 and to preserve protein activity, 8 a feature that likely evolved under selective pressure. Pathogenic bacteria, however, employ enzymes with highly reactive and surface-exposed Cys. 9, 10 These enzymes promote the successful establishment of bacterial infection by helping bacteria circumvent host defenses. 11−13 In addition, the cell host defense mechanism also involves a burst of ROS, which can lead to overoxidation; nevertheless, these enzymes manage to avoid irreversible inactivation 13 by employing mechanisms that involve catalytic and noncatalytic Cys. For example, the catalytic sulfur atom on Cys can react with a nearby nitrogen atom to form a sulfenylamide. 14 A noncatalytic Cys, usually termed a "backdoor" residue, can form a reversible disulfide bond with the catalytic Cys. This bond can also be formed between two noncatalytic backdoor Cys residues as seen in several phosphatases, 15−18 including the low-molecular weight protein tyrosine phosphatase family (LMW-PTPs). 19 Overall, these noncatalytic Cys residues can be found in pairs, clusters, in a single place or in multiple places within the protein structure. They can function as redox switches and have enhanced interplay when clustered, which provides a suitable environment to prevent irreversible inactivation. 20, 21 These features point to an elaborate, synergistic interplay among Cys residues in bacterial phosphatases, especially with noncatalytic residues. This fact also demands an in-depth analysis of their role in virulence effectors of pathogenic bacteria. The reactivity and localization of these noncatalytic Cys residues can be further exploited for drug design approaches as their role may prove to be critical for the maintenance of Cys-containing proteins. 18 In fact, noncatalytic Cys residues have already proven to be effective targets in Food and Drug Administration (FDA)-approved drugs like the kinase-targeting ibrutinib. 22 However, the crucial point lies in the identification of which Cys residues merit further investigation; therefore, a strategy for readily revealing their roles in protein structure and activity may better inform the design of new antibacterial drugs. In this context, we seek to demonstrate how a recently developed method, which uses a chemical mutagenesis approach, can be confidently used to shed light on the role of noncatalytic Cys residues in bacterial enzymes and facilitate the discovery of suitable targets for antibacterial therapeutics. Our main goal is not to exhaustively describe and discuss the reactions developed so far for chemical site-selective protein modification that can be found in recent reviews; 23−27 instead, we will focus on the potential and progress of such reactions in "posttranslational chemical mutagenesis", 28−30 a methodology that enables the modification of specific residues within the protein target, which permits the incorporation of synthetic modifications to explore amino acid side-chain diversity. 31, 32 This Perspective will give detailed insight into this exciting emerging area and provide robust information about an alternative use: to reveal the role(s) of unpaired Cys residues in the structure and function of disease relevant proteins to advocate, hopefully, for its addition to the current chemical biology tool kit used to probe Cys reactivity ( Figure 1 ). The first use will be in bacterial phosphatases, and the ultimate use is to study the interplay between Cys residues in a diverse panel of multiple Cyscontaining proteins relevant in disease.
■ PROBING CYS REACTIVITY IN PTPS
Proteome-wide Analysis. As a result of the susceptibility of the thiol side chain to ROS, and its involvement in the direct regulation of PTPs, 33 the first methods for probing Cys reactivity were developed to detect oxidized PTPs. 34 The most common, indirect techniques rely on the ability of active PTPs to react stoichiometrically and irreversibly with alkylating agents, i.e., iodoacetic acid (IAA) or N-ethylmaleimide, and the resistance of oxidized PTPs to alkylation. Generally, cells are lysed in the presence of a labeled alkylating agent (e.g., radioactive), and oxidation is monitored with a decrease in the level of detection of that probe. Oxidized PTPs are converted Figure 1 . Overview of a posttranslational mutagenesis approach for probing the amino acid sequence, structure, and activity of multiple Cyscontaining proteins. A chemical probe, in this case α,α′-dibromo-adipyl(bis)amide, designed to react with free Cys residues and convert these into Dha is incubated with the respective native Cys protein. PTM protein Dha-protein is assessed for enzymatic activity or binding activity. Once the effect on the activity or structure is assigned, the preferentially modified residue(s) is identified by mass spectrometry. A single plasmid construct that contains an Ala or Ser substitution of the preferentially modified residue(s) is cloned and expressed. The recombinant mutant protein is assessed, and the role of the modified residues in the structure (by circular dichroism for secondary structural content and, for example, by molecular dynamics simulations for local structural changes) and activity is confirmed. For the molecular dynamics simulations, structural ensembles derived from 0.5 μs molecular dynamics simulations on chemical mutant Dha53 of PtpA. Both the global three-dimensional shape and the local structure of the protein are retained upon chemical mutation. Cys11 and Cys16 of the active site are also shown.
into the active state (by using reducing agents), captured, and detected by using a PTP-reactive probe (e.g., biotin-tagged IAA). 35 Although effective at detecting oxidized PTPs, these approaches failed to depict other reactive noncatalytic Cys because the outcome depends mostly on enzyme activity [e.g., in-gel phosphatase assay, IAP-biotin, and activity-based probes (ABPs) 36 ]. In addition, the alkylating agent added to the reaction mixture invariably modifies all reduced Cys residues except the oxidized residue, which prevents an understanding of the intrinsic Cys reactivity and their interplay. Furthermore, the antibodies used to detect oxidized PTPs in proteomic analysis are raised against the conserved PTP signature motif VHC SO 3 H SAG, which covers only the catalytic cleft. 37 Although useful, this approach probes only oxidized catalytic Cys. This caveat is also present in the analysis of recombinantly expressed PTPs, which makes the study of the interplay between Cys residues difficult. However, over the past few years, more direct and improved approaches have been developed (recently reviewed 38 ), based on Cys-reactive probes, which enabled the analysis of highly reactive Cys residues regardless of their catalytic nature. 10 These new approaches were based on the pioneering work by Cravatt and co-workers. 39 The authors developed an activity-based protein profiling probe called isoTOP-ABPP (isotopic tandem orthogonal proteolysis activity-based protein profiling) that, combined with liquid chromatography−tandem mass spectrometry analysis, allowed the identification of highly reactive noncatalytic Cys residues in different proteomes. Their findings also revealed that some of the identified noncatalytic Cys residues possessed a previously unknown function and were significantly more conserved in eukaryotic organisms. Their findings provided strong evidence that noncatalytic Cys residues play essential roles in the proteome and merit special attention. Reasonably, proteome-wide reactivity profiling aids in the identification of highly reactive noncatalytic Cys residues, both in proteomic analysis and in purified protein systems. However, the functional assignment of the identified residues still requires detailed kinetic and mutagenic experiments. In this scenario, we believe that our methodology may be useful in targeted chemical mutagenesis for studying specific protein targets. If one multiple Cys-containing protein is selected, then no structural or activity information is available. Usually, to probe new functionalities, a previous putative role is assigned to the amino acids to be studied, based generally on conserved structural motifs identified through bioinformatics. Thus, consecutive rounds of cloning, expression, and purification are required for each targeted mutation, which may result in a time-consuming, trial-and-error investigation. To facilitate inquiry into the functionality of new amino acids, a direct, chemistry-driven mutagenesis approach can be used to obtain otherwise unknown information about the function and interplay of specific amino acid(s). For example, by targeting the most reactive Cys within a protein with multiple Cys residues, suitable chemical probes used in a posttranslational chemical mutagenesis can provide new insights into the reactivity and role(s) of the preferentially modified residue(s). Site-directed mutagenesis is employed because the residue(s) is identified by mass spectrometry. Upon in vitro confirmation, the role of the chemically modified residues can be further evaluated in transiently transfected cells or stably by expressing cell lines that contain the Cys mutant form of the protein target. In this way, a more biologically relevant protein activity or regulation can be uncovered.
Posttranslational Chemical Mutagenesis. Chemical biologists have been designing chemical probes for Cys modification since 1965, when Wilchek and colleagues demonstrated the conversion of serine (Ser) into Cys in small peptides. 40 Wilchek's work demonstrated how the protein amide backbone and side chains could be exploited for selective chemical mutagenesis. Soon thereafter, new milestones in chemical mutations on proteins were achieved ( Table 1) . Some of the first examples of chemical mutagenesis used conditions that were considered to be harsh for proteins. For example, in the pioneering work by Clark and Lowe, the nucleophilic Cys of papain was chemically converted into Ser by means of alkylation with phenacyl bromide and subsequent photolysis and reduction with NaBH 4 . 41 Basic or acidic conditions, high temperatures, organic solvents, and other non-ideal conditions have been used continuously until recently. In addition, these reactions suffered from poor selectivity, which results in a mixture of modified products at different sites within the protein sequence. To avoid these drawbacks, improved reagents and site-selective chemical reactions that proceed efficiently under mild conditions were developed. 23−27 These new reactions proved to be reliable alternatives to maintain, or even extend, protein activity without disrupting how it folds, for instance, fluorescently tagged proteins for imaging in which a precise position for modification is required, 26, 27 antibody−drug conjugates used for cancer diagnostics, and delivery payloads of antitumor drugs. 24, 42 In addition, these reactions enabled the chemoselective labeling of ribosomally incorporated noncanonical amino acids that bear unnatural side chains such as alkynes, alkenes, tetrazines, ketones, and azides on endogenously expressed proteins. 43, 44 These unusual side chains permitted bioorthogonal protein labeling and functionalization, which facilitates a detailed understanding of biological processes and biomolecules within their native habitat, cells and live organisms. 45 Another use of site-selective modification is the specific installation of suitable mimics of posttranslational modifications (PTMs) in recombinantly expressed proteins at defined positions to study and modulate enzyme activity. In a seminal work, Davis 46 and colleagues engineered a Cys on the surface of kinase p38α. The same group has previously described the use of α,α′-dibromo-adipyl(bis)amide to selectively convert Cys into dehydroalanine (Dha). 47 Subsequently and through thiol-Michael addition with sodium thiophosphate, a phosphoCys mimic is installed. 46 The similarity of phospho-Cys to naturally occurring phospho-Tyr was sufficient to switch the kinase to its active form. Several synthetic mimics of PTMs were facilitated by the ability to generate Dha in a site-selective way on proteins. A regioisomer of histidine (His), iso-His (His iso ), installed through β,γ-C,N aza-Michael mutagenesis was used to probe the contributing roles of size and hydrogen bonding in the activity of Mycobacterium tuberculosis (Mtb) pantothenate synthetase (PanC). 48 His mimic H44His iso , which lacks the ability to donate H-bonds, provided the mechanistic detail for the inhibition of PanC. The chemical mutant preferentially adopted a rotamer that is oriented toward the solvent, which made it unable to interact with the β-phosphate from ATP. PanC ATP-dependent condensation activity is important for the formation of vitamin B 5 (panthothenate), on which Mtb relies to grow and for the proper function of its virulence factors. 49 Because of its important activity, PanC is also a target for anti-tuberculosis therapy. Interestingly, the same mimic His iso , installed in the protease subtilisin from Bacillus lentus (S156His iso ), revealed that H-bond donors are not necessary to maintain enzymatic activity. 48 Acetylated and methylated Lys mimics were also produced by site-selective chemical mutagenesis and successfully used to study writer/erase activity of histone deacetylases (HDACs) in chromatin modification. 50 To date, the acetyl-Lys mimic installed through Dha in this study is the most convenient way to investigate HDAC activity on full-length histones. Dha is currently used as a chemical precursor of mono-, di-, and trimethylated Lys, acetylated Lys, phosphorylated Ser, and glycosylated Ser and has proven to be a reliable chemical handle for mimicking PTMs and modulating enzymatic activity. 46 Interestingly, what the aforementioned approaches do not address are the reasons why nature has evolved to enhance the reactivity of particular side chains within a protein sequence and what are the structural and functional consequences. Why, in a complex mixture of residues spread along the protein sequence, do some residues have enhanced reactivity that allows them to be preferentially chemically modified? Do they have a structural or functional role? Do physicochemical properties dictate their reactivity? Does reactivity mean that these residues perform a special role? The case is not simple for Cys, but it may provide insights into why a preferentially modified Cys in a multiple-Cys-containing protein might play an important role in redox sensing, binding to an antigen, or catalytic activity. 9 It is recognized that structural context dictates reactivity, and highly polarizable sulfhydryl side chains are often presented in buried motifs, 8 which affects their accessibility and protonation state. Secondary structures, such as α-helices, can exhibit a dipole moment with a positive charge at the N-terminal end, which decreases the pK a and makes the Cys residues located within these constraints more reactive. 51 Such features enhance Cys nucleophilicity by reducing its pK a from an "unperturbed" value of 8.5
52 to values as low as 3.5. 53 In addition, some proteins have specialized catalytic pocket designs that also strongly enhance the reactivity of Cys toward specific substrates, such as peroxiredoxins. 54 Often, if there are two free Cys units, the reactivity of one is dependent of the other. Understanding Cys reactivity and interplay in this context might prove to be a challenge.
To address this challenge, we developed an approach that combined Dha-based chemical mutagenesis with site-directed mutagenesis. We hypothesized that Cys-to-Dha converter compound α,α′-dibromo-adipyl(bis)amide could react with highly reactive Cys in multiple Cys-containing bacterial phosphatases in accordance with Cys reactivity, which may highlight a possible key role. We then tested the Cys high reactivity/key function correlation by producing mutants of the preferentially modified residues and analyzing the structure and enzymatic activity of both chemical and site-directed mutants (Figure 1 ). Our findings indicated that a Dha-based posttranslational chemical mutagenesis can be used as means to interrogate Cys function. We present here two case studies on which to base this assertion.
Case Study 1: Noncatalytic Cys16 and Cys53 from M. tuberculosis Protein Tyrosine Phosphatase A (PtpA). Our analysis of PtpA provides the first evidence to support the use of posttranslational chemical mutagenesis in revealing the critical role of noncatalytic Cys residues in bacterial phosphatases. 9 PtpA possesses three Cys residues, Cys11, Cys16, and Cys53, and its phosphatase activity relies on the nucleophilicity and reactivity of catalytic Cys11. As a result of PtpA dephosphorylation activity, Mtb is able to avoid the macrophage proteolysis machinery. PtpA disrupts key components of the macrophage endocytic pathway, which leads to the inhibition of phagosome maturation and its late fusion with the lysosome, which ultimately allows Mtb to survive inside the host macrophages. 62, 63 As a result of its key activity, PtpA has become an important druggable target in anti-tuberculosis chemotherapy. 64, 65 To probe Cys reactivity and function in PtpA, we applied our posttranslational chemical mutagenesis approach (Figure 1 ). In this new approach, in vitro reactions of recombinant PtpA and an increasing number of equivalents of α,α′-dibromo-adipyl(bis)-amide were performed under mild conditions [50 mM NaH 2 PO 4 (pH 8.0)]. The reaction resulted in a single protein population with one modified Cys after incubation for 1 h with 75 equiv of reagent at 37°C. Surprisingly, the selective single modification was achieved readily and without further optimization. Upon tandem mass spectrometry analysis of the singly modified protein digests, Cys53 (Dha53) was identified as being preferentially modified. Structural (circular dichroism and molecular dynamics) and functional (phosphatase activity) assays revealed that the conformation and phosphatase activity of the Dha53 mutant were not altered relative to those of nonmodified PtpA. Subsequently, to corroborate the results from chemical mutagenesis, a sitedirected C53A mutant was produced and its activity profile analyzed relative to that of the Dha53 mutant. As expected, the C53A mutant presented the same phosphatase activity as the wild type and Dha53 mutant. Previously, Cys53 had been identified as a target of S-nitrosylation by nitric oxide; 66 however, in this case the phosphatase activity was partially suppressed, which could be an indication that Cys53 is a regulatory site, modulated by nitric oxide.
Intrigued by these findings, we decided to submit the protein variants (wild type, Dha53 mutant, and C53A mutant) to incubation with H 2 O 2 and nitric oxide. Surprisingly, the chemical Dha53 and C53A mutants were extremely prone to Biochemistry Perspective H 2 O 2 inactivation relative to the wild type and failed to be Snitrosylated by NO. These findings have shown that the Dhabased posttranslational chemical mutagenesis facilitated the discovery of noncatalytic Cys53 as an oxidation-sensitive residue involved in a redox regulation mechanism; thus, it functions as a scavenger of ROS and RNS and reduces the level of overoxidation of catalytic Cys11. There is still the need to corroborate the role of Cys53 in the cellular activity and regulation of PtpA, and our results made its investigation in Mtb infection even more promising. The crystal structure of PtpA further showed that Cys53 was surface-exposed and the solvent accessibility was the first answer for its preferential modification by the α,α′-dibromo-adipyl(bis)amide compound (Figure 2) . A prolonged protein incubation time with α,α′-dibromo-adipyl(bis)amide revealed an incomplete stoichiometric correlation in the chemical reactions, because it was not possible to modify all of the PtpA's Cys residues completely under mild conditions.
In addition, failed attempts to chemically modify sitedirected double mutant C11/53A, which contains only Cys16, and the combined FTIR findings of disturbed O−H stretches in Dha11 and C11S mutants led us to identify noncatalytic Cys16 as a "backdoor" residue for our newly discovered Cys− Cys water-bridged motif (Figure 3) . The elegant interplay between these noncatalytic residues (Cys16 and Cys53) shows how PtpA may prevent critical inhibition of its phosphatase activity under oxidative stress. 9 More fascinating is the fact that all this new information in regard to new structural motifs and regulation in PtpA may be used to design innovative antituberculosis (anti-PTP) drugs. As a start, the design of Cysdirected electrophilic drug-like molecules that react preferentially with Cys53, which may disrupt its role as scavenger, by making the protein more susceptible to oxidative damage or by inducing structural changes may lead to an inactive PtpA conformation. Targeting highly reactive noncatalytic Cys residues, such as Cys53, in PtpA with small molecules may avoid off-targets in drug development because it is not conserved among PTPs. 9 In fact, drug design strategies, like tethering and covalent fragment-based ligand discovery, can aid in the development of such small molecules. 67 These medicinal chemistry approaches have indeed led to the generation of FDA-approved drugs such as kinase inhibitor ibrutinib and EGFR inhibitor afatinib, both of which target highly reactive noncatalytic Cys residues. 68, 69 New drugs could also be designed to target backdoor Cys16 and then disrupt the Cys−Cys water-bridged motif. Similar findings that involve cryptic Cys residues, such as Cys333 in PTP Shp2, support this argument, 70 which suggests that buried-yet-targetable allosteric sites can be used as scaffolds in computationally aided drug discovery. Because this new motif is also found in other bacterial phosphatases, 9 a drug design strategy that targets it could be an interesting alternative for fighting resistant strains. Nevertheless, to avoid off-target effects, parallel experiments must be performed to show if the Cys−Cys water-bridged motif is also present in the host's phosphatases.
Case Study 2: Noncatalytic Cys259 from Yersinia enterocolitica Protein Tyrosine Phosphatase YopH. YopH tyrosine phosphatase from Yersinia uses its catalytic Cys403 residue to hydrolyze a phosphotyrosine substrate, which usually involves the formation of a Cys−phosphate intermediate. YopH contains an N-terminal signal, a chaperone binding region, and a PTPase catalytic C-terminal domain, which is conserved among PTPs. 71 YopH Cys-phosphatase activity prevents invasin-triggered internalization of bacteria by disrupting the focal adhesion complex 12, 72 and suppresses the oxidative burst in macrophages and neutrophils. 72 A combined inactivation of PRAM-1/SKAP-HOM and SLP76/Vav/PLCγ2 signal transduction axes and the modulation of lymphocytic activation ultimately mediates the survival of Yersinia. 73 Moreover, YopH contains four additional Cys residues in addition to catalytic Cys403. Intriguingly, when YopH was submitted to the same posttranslational chemical reactions as PtpA, it yielded once again preferential modifications at noncatalytic Cys residues, except this time the preferentially modified Cys259 was located in a buried motif (Figure 2) . A closer look at the crystal structure revealed that Cys259 is in the proximity with Cys403, so these residues might interact with each other.
9 Cys259 in YopH may also act as "backdoor" Cys and play a role similar to that of Cys16 in PtpA. The presence of the Cys−Cys water-bridged motif in YopH remains to be confirmed. However, this new structural motif, which involves noncatalytic Cys units, is also present in SptpA 9 from Staphylococcus aureus and is likely conserved within the LMW-PTP family (Figure 3) .
Our results clearly show that the α,α′-dibromo-adipyl(bis)-amide compound was able to distinguish residues based intrinsically on Cys reactivity and that such reactivity is not necessarily determined by solvent accessibility, structural, or folding constraints. It is, however, affected by a combination of all these features within the local environment and is highly protein-specific. This feature makes Dha-based posttranslational chemical mutagenesis a robust methodology for generating point mutations in folded proteins and highlighting intrinsic functionalities of its reactive Cys counterparts. In combination with site-directed mutagenesis, a detailed overview of protein dynamics can be achieved and critical and conserved new binding motifs revealed.
■ EXTENDING THE PLATFORM TO OTHER BACTERIAL PHOSPHATASES WITH MULTIPLE NONCATALYTIC CYS RESIDUES
Bacterial phosphatases with multiple noncatalytic Cys residues are typically involved in polysaccharide production and as secreted virulence effectors, which downregulate the host cell signaling pathways. 74 SptP, a tyrosine phosphatase from Salmonella typhimurium, is another enzyme that relies on its Cys481 catalytic residue to circumvent host immune defenses. 11 It shares 30% sequence homology with YopH and is very similar structurally and enzymatically to this enzyme, except for the shape and charge distribution of its catalytic site. 75 SptP GAP activity inhibits signaling through Rho GTPases Rac-1 and Cdc42, which leads to rearrangements in the actin cytoskeleton in host cells. 76 Similar to other secreted phosphatases, SptP suppresses the recruitment of neutrophils by dephosphorylating the vesicle fusion protein Nethylamide-sensitive factor, which impedes the degranulation of local mast cells and facilitates bacterial spread. 77 Interestingly, SptP shares another structural feature with YopH, the presence of multiple noncatalytic Cys units, with unknown functions. TpbA tyrosine phosphatase from Pseudomonas aeruginosa is among the dual-specificity phosphatases that employ a catalytic Cys132 residue to dephosphorylate tyrosine, Ser, and threonine residues in host proteins. 78 Successful Pseudomonas infection is linked to its ability to form biofilms in a polymeric matrix. 79 Critically, TpbA reduces the level of biofilm formation by attenuating the activity of TpbB, which leads to a reduced concentration of 3,5-cyclic diguanylic acid. This cyclic nucleotide is a second messenger that modulates the transcription of important genes involved in biofilm production and, consequently, is important for the establishment of infection. 80 TbpA inactivation promotes rugose colony morphology, which is related to cell persistence in clinical infections. 80 TpbA also contains another two noncatalytic Cys residues spread along the amino acid sequence, which to date have no assigned function. Another example of multiple-Cys-containing bacterial phosphatase is the SP-PTP from Streptococcus pyogenes. SP-PTP possesses an N-terminal C(X) 5 R(S/T) signature motif that is conserved in all LMW-PTPs, 81 and its catalytic function is linked to its Cys8 residue, which allows growth, cell division, cell adherence, and invasion of host cells. Once again, this phosphatase contains four other noncatalytic Cys residues distributed along its amino acid sequence. 82 These phosphatases represent good examples in which a Dha-based chemical mutagenesis approach may provide new relevant information about the function and interplay of noncatalytic Cys residues. This argument is strengthened by the fact that highly reactive noncatalytic Cys residues have already proven to be critical players in the survival of pathogenic bacteria under oxidative stress. 10 
■ CONCLUSION AND OUTLOOK
Bacterial phosphatases play key roles and, in most cases, enable the successful survival of highly pathogenic bacteria inside human hosts, which represents a challenge for antibacterial therapeutics especially in multi-drug-resistant bacteria. As shown in this Perspective, a posttranslational chemical mutagenesis approach based on site-selective chemical modifications at Cys residues can be extended to produce diverse protein conjugates and applied to reveal previously unknown amino acid functions in a biologically relevant context. As we have shown with the phosphatases, developing a drug-oriented strategy that uses information provided by posttranslational mutagenesis may prove to be effective. The reactivity of the designed chemical probes and the residues of which they preferentially target can yet reveal unusual structural motifs and regulatory effects, which can then be targeted in an alternative and more direct drug design platform. The structural information may ultimately drive the synthesis of potent allosteric inhibitors. Eventually, by revealing important noncatalytic residues, we can extend this platform to a vast set of proteins, not just enzymes, and structural proteins. This panel can include transcription factors, DNA and RNA binding proteins, receptors, and chaperones. We have successfully tested the feasibility of the platform in a chaperone (manuscript submitted for review) and in an RNA binding protein (unpublished). Finally, as this robust chemical biology strategy develops over the next few years, it will afford a fast way to uncover the functionality of other key residues, such as lysines, 83, 84 will aid in the answer of challenging biological questions, and may ultimately mediate the development of a better and more specific drug design platform.
